Bausch + Lomb wins FDA panel vote for eye implant

04/9/2013 | MassDevice.com (Boston)

A panel of FDA advisers has voted in favor of recommending approval for Bausch + Lomb's Trulign Toric device, designed for patients who have undergone cataract-removal surgery. The posterior chamber intraocular lens is implanted in the eye's capsular bag to visually correct postoperative refractive astigmatism and aphakia in adult patients.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC